Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Physiological evidence for diversification of IFNα- and IFNβ-mediated response programs in different autoimmune diseases.
Devic's disease before Devic: Bilateral optic neuritis and simultaneous myelitis in a young woman (1874).
[NMO spectrum disorder].
Reduced cortical microvascular oxygenation in multiple sclerosis: a blinded, case-controlled study using a novel quantitative near-infrared spectroscopy method.
Disclosure of diagnosis of multiple sclerosis in the workplace positively affects employment status and job tenure.
Translating CESD-20 and PHQ-9 Scores to PROMIS Depression.
Understanding disease processes in multiple sclerosis through magnetic resonance imaging studies in animal models.
Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial.
Concurrent acute disseminated encephalomyelitis and Guillain-Barré syndrome in a child.
Exogenous leukemia inhibitory factor stimulates oligodendrocyte progenitor cell proliferation and enhances hippocampal remyelination.
Indices of Cognitive Dysfunction in Relapsing-Remitting Multiple Sclerosis: Intra-individual Variability, Processing Speed, and Attention Network Efficiency.
Does antiretroviral therapy for HIV reduce the risk of developing multiple sclerosis?
Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid.
The need for randomization in animal trials: an overview of systematic reviews.
A critical appraisal of daclizumab use as emerging therapy in multiple sclerosis.
Neural drive increases following resistance training in patients with multiple sclerosis.
[NLRP3 inflammasome and multiple sclerosis/EAE].
Aquaporin-4 immuneglobulin g testing in 36 consecutive jamaican patients with inflammatory central nervous system demyelinating disease.
Comparing voice self-assessment with auditory perceptual analysis in patients with multiple sclerosis.
Alemtuzumab in the treatment of multiple sclerosis: key clinical trial results and considerations for use.
Primary spinal oligoastrocytoma mimicking longitudinally extensive transverse myelitis.
Chronic constipation and co-morbidities: A prospective population-based nested case-control study.
Tumefactive demyelinating lesions as a first clinical event: Clinical, imaging, and follow-up observations.
Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica.
Inflammatory response of endothelial cells to a human endogenous retrovirus associated with multiple sclerosis is mediated by TLR4.
Pages
« first
‹ previous
…
486
487
488
489
490
491
492
493
494
…
next ›
last »